A citation-based method for searching scientific literature

Ellen M Mikkelsen, Lone Sunde, Christoffer Johansen, Søren P Johnsen. Cancer Detect Prev 2007
Times Cited: 14







List of co-cited articles
167 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Patients' resistance to risk information in genetic counseling for BRCA1/2.
Andrea D Gurmankin, Susan Domchek, Jill Stopfer, Christina Fels, Katrina Armstrong. Arch Intern Med 2005
62
50

The use of videotaped information in cancer genetic counselling: a randomized evaluation study.
A Cull, H Miller, T Porterfield, J Mackay, E D Anderson, C M Steel, R A Elton. Br J Cancer 1998
97
35

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
M Watson, S Lloyd, J Davidson, L Meyer, R Eeles, S Ebbs, V Murday. Br J Cancer 1999
182
35

Breast cancer risk counseling improves women's functioning.
Deborah J Bowen, Wylie Burke, Anne McTiernan, Yutaka Yasui, M Robyn Andersen. Patient Educ Couns 2004
54
35

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
60
35

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
127
35

Validity of models for predicting BRCA1 and BRCA2 mutations.
Giovanni Parmigiani, Sining Chen, Edwin S Iversen, Tara M Friebel, Dianne M Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, Barbara L Weber, Andrea Eisen, Kathleen E Malone,[...]. Ann Intern Med 2007
75
35

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
35

Assessing BRCA carrier probabilities in extended families.
Carlos H Barcenas, G M Monawar Hosain, Banu Arun, Jihong Zong, Xiaojun Zhou, Jianfang Chen, Jill M Cortada, Gordon B Mills, Gail E Tomlinson, Alexander R Miller,[...]. J Clin Oncol 2006
70
35

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
35

Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kimberly M Kelly, Leigha Senter, Howard Leventhal, Gozde Ozakinci, Kyle Porter. Patient Educ Couns 2008
13
38

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
35


Development of a risk assessment tool for women with a family history of breast cancer.
Dejana Braithwaite, Stephen Sutton, James Mackay, Judith Stein, Jon Emery. Cancer Detect Prev 2005
26
35

A systematic review of the impact of genetic counseling on risk perception accuracy.
Chris M R Smerecnik, Ilse Mesters, Eline Verweij, Nanne K de Vries, Hein de Vries. J Genet Couns 2009
83
35

A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.
P Hopwood, D Wonderling, M Watson, A Cull, F Douglas, T Cole, D Eccles, J Gray, V Murday, M Steel,[...]. Br J Cancer 2004
20
35

A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.
A Fry, A Cull, S Appleton, R Rush, S Holloway, D Gorman, R Cetnarskyj, R Thomas, J Campbell, E Anderson,[...]. Br J Cancer 2003
38
35

Randomized trial of a specialist genetic assessment service for familial breast cancer.
K Brain, J Gray, P Norman, E France, C Anglim, G Barton, E Parsons, A Clarke, H Sweetland, M Tischkowitz,[...]. J Natl Cancer Inst 2000
69
28



A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style.
C Lerman, M D Schwartz, S M Miller, M Daly, C Sands, B K Rimer. Health Psychol 1996
141
28

Family history of breast cancer: what do women understand and recall about their genetic risk?
M Watson, V Duvivier, M Wade Walsh, S Ashley, J Davidson, M Papaikonomou, V Murday, N Sacks, R Eeles. J Med Genet 1998
110
28

Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.
P Hopwood, F Keeling, A Long, C Pool, G Evans, A Howell. Psychooncology 1998
89
28


Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
544
28

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
388
28

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
28

Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population.
Cecelia A Bellcross, Amy A Lemke, Laura S Pape, Angela L Tess, Lorraine T Meisner. Genet Med 2009
70
28

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
40
28

Effects of a telephone counseling intervention on sisters of young women with breast cancer.
Joan R Bloom, Susan L Stewart, Susan Chang, Myoungsoon You. Prev Med 2006
21
28


A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.
A C Antoniou, P D P Pharoah, G McMullan, N E Day, M R Stratton, J Peto, B J Ponder, D F Easton. Br J Cancer 2002
313
28

The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.
K Brain, E Parsons, P Bennett, R Cannings-John, K Hood. Psychooncology 2011
10
40

Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for affected versus unaffected women.
Arwen H Pieterse, Margreet G E M Ausems, Peter Spreeuwenberg, Sandra van Dulmen. Patient Educ Couns 2011
27
28


Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
288
28

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005
832
28

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
128
28

Results of a randomized study of telephone versus in-person breast cancer risk counseling.
Almut W Helmes, Julie O Culver, Deborah J Bowen. Patient Educ Couns 2006
54
28

Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment.
Paul Bennett, Clare Wilkinson, Jim Turner, Rhiannon Tudor Edwards, Barbara France, Gethin Griffith, Jonathon Gray. Fam Cancer 2009
15
28

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, F Lalloo. J Med Genet 2004
182
28

Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
143
28

Selecting a BRCA risk assessment model for use in a familial cancer clinic.
Seema M Panchal, Marguerite Ennis, Sandra Canon, Louise J Bordeleau. BMC Med Genet 2008
32
28


Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes.
E A Lobb, P N Butow, A Barratt, B Meiser, C Gaff, M A Young, E Haan, G Suthers, M Gattas, K Tucker. Br J Cancer 2004
97
28



Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women.
A Bish, S Sutton, C Jacobs, S Levene, A Ramirez, S Hodgson. Br J Cancer 2002
81
21

Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review.
Phyllis N Butow, Elizabeth A Lobb, Bettina Meiser, Alexandra Barratt, Katherine M Tucker. Med J Aust 2003
123
21

Risk communication in genetic testing for cancer susceptibility.
R T Croyle, C Lerman. J Natl Cancer Inst Monogr 1999
111
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.